Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Liso

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Blood|June 1, 1997
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphomaP L Zinzani, E Pavone, S Storti, et al.
Blood|August 15, 2000
A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangementsD Sainty, V Liso, A Cantù-Rajnoldi, et al.
Leukemia|April 19, 2006
Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemiaM Trubia, F Albano, F Cavazzini, et al.
Bone Marrow Transplantation|January 29, 2013
Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centersA Bazarbachi, M Labopin, A Ghavamzadeh, et al.
Blood|August 15, 2000
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies"D Grimwade, A Biondi, M J Mozziconacci, et al.
Blood|August 15, 2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groupsM A Sanz, F Lo Coco, G Martín, et al.
Leukemia|August 30, 2002
Acute megakaryoblastic leukemia: experience of GIMEMA trialsL Pagano, A Pulsoni, M Vignetti, et al.
Blood|August 1, 1997
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative GroupsF Mandelli, D Diverio, G Avvisati, et al.
Leukemia|June 22, 2001
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patientsG Visani, P Bernasconi, M Boni, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Blood|June 1, 1997
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphomaP L Zinzani, E Pavone, S Storti, et al.
Blood|August 15, 2000
A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangementsD Sainty, V Liso, A Cantù-Rajnoldi, et al.
Leukemia|April 19, 2006
Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemiaM Trubia, F Albano, F Cavazzini, et al.
Bone Marrow Transplantation|January 29, 2013
Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centersA Bazarbachi, M Labopin, A Ghavamzadeh, et al.
Blood|August 15, 2000
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies"D Grimwade, A Biondi, M J Mozziconacci, et al.
Blood|August 15, 2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groupsM A Sanz, F Lo Coco, G Martín, et al.
Leukemia|August 30, 2002
Acute megakaryoblastic leukemia: experience of GIMEMA trialsL Pagano, A Pulsoni, M Vignetti, et al.
Blood|August 1, 1997
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative GroupsF Mandelli, D Diverio, G Avvisati, et al.
Leukemia|June 22, 2001
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patientsG Visani, P Bernasconi, M Boni, et al.
Pageof 14